LXEO peer analysis
Lexeo Therapeutics (LXEO) against its competitors: price, today's move, 1-year return and market value side by side.
LXEO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AMRN Amarin | $11.38 | -2.49% | -28.01% | $5.16B |
| CAPR Capricor | $8.18 | -14.17% | 50.32% | $539.74M |
| CTNM Contineum Therapeutics | $9.65 | -2.13% | -14.04% | $387.16M |
| DBVT DBV Technologies | $10.30 | -6.49% | -19.83% | $264.10M |
| KYTX Kyverna Therapeutics | $4.75 | -5.94% | -25.70% | $344.33M |
| LRMR Larimar Therapeutics | $3.02 | 0.00% | -11.57% | $309.57M |
| MREO Mereo BioPharma | $0.31 | 0.82% | -83.42% | $243.54M |
| SLN Silence Therapeutics | $19.80 | -0.13% | 194.67% | $936.70M |
| VNDA Vanda Pharmaceuticals | $3.82 | -4.26% | -8.16% | $244.90M |
| VYGR Voyager Therapeutics | $1.62 | -6.36% | -58.59% | $109.52M |
| LXEO Lexeo Therapeutics | $3.22 | 12.20% | -68.19% | $240.52M |
- LXEO's peers: AMRN (Amarin), CAPR (Capricor), CTNM (Contineum Therapeutics), DBVT (DBV Technologies), KYTX (Kyverna Therapeutics), LRMR (Larimar Therapeutics), MREO (Mereo BioPharma), SLN (Silence Therapeutics).
Updated 2026-11-16 23:45 UTC